F-group (family)
2008.1.1.1 Flu_PA
Ligands and drugs
492
Member domains
281
with ligand contacts (≤ 4 Å)
57.1% of members
257
with DrugDomain annotations
52.2% of members
170
with a DrugBank compound
34.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2008.1.1.1 belongs to X-group 2008 Restriction endonuclease-like, which binds 7.5 ligand superclasses per 20 proteins, narrower than 52% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB15675 | E4Z | Baloxavir | 18 |
| DB01643 | TMP | Thymidine monophosphate | 10 |
| DB03685 | U5P | Uridine monophosphate | 8 |
| DB06817 | RLT | Raltegravir | 5 |
| DB01672 | DBH | 2,3-Dihydroxy-Benzoic Acid | 4 |
| DB00131 | AMP | Adenosine phosphate | 2 |
| DB00142 | GLU | Glutamic acid | 1 |
| DB02042 | 1PG | 2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol | 1 |
| DB08214 | MSR | 4-(1H-IMIDAZOL-1-YL)PHENOL | 1 |
| DB09459 | TLA | L-tartaric acid | 1 |
| DB12116 | KDH | Epigallocatechin gallate | 1 |
| DB15584 | LU2 | Luteolin | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MNmetal | MANGANESE (II) ION | 238 |
| MGmetal | MAGNESIUM ION | 56 |
| QQ4 | Hexa Vinylpyrrolidone K15 | 41 |
| E4Z | Baloxavir acid | 20 |
| TMP | THYMIDINE-5'-PHOSPHATE | 10 |
| U5P | URIDINE-5'-MONOPHOSPHATE | 8 |
| XI7 | 2-4-DIOXO-4-PHENYLBUTANOIC ACID | 8 |
| 0N8 | (2Z)-4-[1-benzyl-4-(4-chlorobenzyl)piperidin-4-yl]-2-hydroxy-4-oxobut-2-enoic acid | 5 |
| RLT | N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}ethyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide | 5 |
| 0N7 | 2-hydroxyisoquinoline-1,3(2H,4H)-dione | 4 |
| 0N9 | 5-hydroxy-2-(1-methyl-1H-imidazol-4-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxylic acid | 4 |
| 581 | 2-[3-(acetylamino)phenyl]-5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxylic acid | 4 |
| A1J4F | 9-oxidanyl-6-[(1-phenylcyclohexyl)methyl]-2-propan-2-yl-3,4-dihydropyrazino[1,2-c]pyrimidine-1,8-dione | 4 |
| CI3 | (2Z)-4-[(3S)-1-benzyl-3-(4-chlorobenzyl)piperidin-3-yl]-2-hydroxy-4-oxobut-2-enoic acid | 4 |
| DBH | 2,3-DIHYDROXY-BENZOIC ACID | 4 |
| M4H | 5-oxidanyl-4-oxidanylidene-1-[(1-pyrrolo[2,3-b]pyridin-1-ylcyclopentyl)methyl]pyridine-3-carboxylic acid | 4 |
| R07 | 1-[(11S)-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-5-hydroxy-3-[(2R)-1,1,1-trifluoropropan-2-yl]-2,3-dihydro-1H-pyrido[2,1-f][1,2,4]triazine-4,6-dione | 4 |
| SL6 | (Z)-4-[4-[(4-chlorophenyl)methyl]-1-(cyclohexylmethyl)piperidin-4-yl]-2-oxidanyl-4-oxidanylidene-but-2-enoic acid | 4 |
| CL | CHLORIDE ION | 3 |
| GY6 | 2-[(2S)-1-(2,6-dichlorobenzene-1-carbonyl)pyrrolidin-2-yl]-5-hydroxy-6-oxo-N-(2-phenylethyl)-1,6-dihydropyrimidine-4-carboxamide | 3 |